Cargando…
The effectiveness of serum S100B, TRAIL, and adropin levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients
INTRODUCTION: More than half of all worldwide deaths and disabilities were caused by stroke. Large artery atherosclerosis is identified as a high etiological risk factor because it accounts for 20% of ischemic stroke. OBJECTIVES: To identify the significance of TRAIL and adropin release and the rela...
Autores principales: | Kadirhan, Ozge Altintas, Kucukdagli, Okkes Taha, Guien, Bedia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Nacional de Salud
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424101/ https://www.ncbi.nlm.nih.gov/pubmed/35866730 http://dx.doi.org/10.7705/biomedica.5943 |
Ejemplares similares
-
Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
por: Yang, Changjun, et al.
Publicado: (2021) -
Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms
por: Bang, Oh Young, et al.
Publicado: (2020) -
Hurdles in stroke thrombolysis: Experience from 100 consecutive ischemic stroke patients
por: Badachi, Sagar, et al.
Publicado: (2015) -
Plasma D-Dimer Levels Are Associated with Stroke Subtypes and Infarction Volume in Patients with Acute Ischemic Stroke
por: Zi, Wen-Jie, et al.
Publicado: (2014) -
Ischemic Stroke Subtype Classification: An Asian Viewpoint
por: Kim, Bum Joon, et al.
Publicado: (2014)